Remove Documentation Remove Packaging Remove White Paper
article thumbnail

How ICH E6 (R3) is changing clinical trials

Pharmaceutical Technology

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? To explore how Zelta can support your organization’s clinical data management needs, download the document below.

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

In addition, documentation of the material is required, along with clearly defined next steps for modification and expansion. How will RFK Jr’s American dream for vaccines play out? Such logistics requires specialists in cold chain logistics, who need to maintain a full chain of custody and ensure traceability.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

To learn more about the solutions provided by Paradigm Health, download the document below. How will RFK Jr’s American dream for vaccines play out? To serve both science and patients, the industry must embrace transformation before inefficiency puts progress out of reach. Sign up for our daily news round-up!

article thumbnail

GSK’s Blenrep US comeback hindered by eye safety concerns

Pharmaceutical Technology

Robert Barrie July 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shares in London-listed GSK closed 1.19% down following the document release. Syngene’s expertise in the field is covered in this white paper. How will RFK Jr’s American dream for vaccines play out? 1take1shot via Shutterstock.

article thumbnail

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Pharmaceutical Technology

The net payment made by Sino to acquire LaNova will be approximately $500.9m, a figure that excludes the estimated cash and bank deposits, according to a company document outlining the terms of the transaction. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

article thumbnail

Can rare disease research in the US thrive under the new administration?

Pharmaceutical Technology

Comstock said it is not yet clear if the report will be turned into an official agency guidance document, but it will be made publicly available. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

FDA
article thumbnail

GSK’s Blenrep faces setback as FDA cancer committee votes against approval

Pharmaceutical Technology

Syngene’s expertise in the field is covered in this white paper. The concern of ocular toxicity was first highlighted in a document published ahead of the ODAC meeting that took place on 17 July. Syngene’s expertise in the field is covered in this white paper. How will RFK Jr’s American dream for vaccines play out?

FDA